Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

ibrutinib 3Imatinib Mesylate 2ruxolitinib 1nilotinib 1bosutinib 1belumosudil 1axatilimab 1Sirolimus 1Rituximab 1Proto-Oncogene Proteins c-raf 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1Methotrexate 1KD025 1Infliximab 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Bronchiolitis Obliterans Syndrome × axatilimab × Clear all
NCT04710576 2026-03-16

AGAVE-201

Syndax Pharmaceuticals

Phase 2 Active not recruiting
241 enrolled 11 charts 1 FDA

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡